Loading
PDBj
メニューPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

4XWH

Crystal structure of the human N-acetyl-alpha-glucosaminidase

4XWH の概要
エントリーDOI10.2210/pdb4xwh/pdb
分子名称Alpha-N-acetylglucosaminidase, beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, ... (7 entities in total)
機能のキーワードglycosidase, hydrolase
由来する生物種Homo sapiens (Human)
タンパク質・核酸の鎖数1
化学式量合計83177.53
構造登録者
Birrane, G.,Meiyappan, M.,Dassier, A. (登録日: 2015-01-28, 公開日: 2016-02-03, 最終更新日: 2023-09-27)
主引用文献Birrane, G.,Dassier, A.L.,Romashko, A.,Lundberg, D.,Holmes, K.,Cottle, T.,Norton, A.W.,Zhang, B.,Concino, M.F.,Meiyappan, M.
Structural characterization of the alpha-N-acetylglucosaminidase, a key enzyme in the pathogenesis of Sanfilippo syndrome B.
J.Struct.Biol., 205:65-71, 2019
Cited by
PubMed Abstract: Mucopolysaccharidosis III B (MPS III-B) is a rare lysosomal storage disorder caused by deficiencies in Alpha-N-acetylglucosaminidase (NAGLU) for which there is currently no cure, and present treatment is largely supportive. Understanding the structure of NAGLU may allow for identification of novel therapeutic targets for MPS III-B. Here we describe the first crystal structure of human NAGLU, determined to a resolution of 2.3 Å. The crystal structure reveals a novel homotrimeric configuration, maintained primarily by hydrophobic and electrostatic interactions via domain II of three contiguous domains from the N- to C-terminus. The active site cleft is located between domains II and III. Catalytic glutamate residues, E316 and E446, are located at the top of the (α/β) barrel structure in domain II. We utilized the three-dimensional structure of NAGLU to map several MPS III-B mutations, and hypothesize their functional consequences. Revealing atomic level structural information about this critical lysosomal enzyme paves the way for the design of novel therapeutics to target the underlying causes of MPS III-B.
PubMed: 30802506
DOI: 10.1016/j.jsb.2019.02.005
主引用文献が同じPDBエントリー
実験手法
X-RAY DIFFRACTION (2.32 Å)
構造検証レポート
Validation report summary of 4xwh
検証レポート(詳細版)ダウンロードをダウンロード

252816

件を2026-04-29に公開中

PDB statisticsPDBj update infoContact PDBjnumon